Stefan Norin
Förmögenhet: 2 784 $ per 2026-08-31
Förmögenhet: 2 784 $ per 2026-08-31
Stefan Norin currently works at Oncopeptides AB, as Chief Medical Officer from 2023.
Mr. Norin also formerly worked at Medivir AB, as Associate Director-Clinical Research & development from 2017 to 2019 and Karolinska University Hospital, as Head-Lymphosection.
Mr. Norin received his doctorate degree from Karolinska Institutet.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-19 | 13 975 ( 0 % ) | 2 784 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| ONCOPEPTIDES AB | Teknisk/Vetenskaplig/F&U Direktör | 2023-09-01 |
| Företag | Position | Slut |
|---|---|---|
| MEDIVIR AB | Teknisk/Vetenskaplig/F&U Direktör | 2019-03-01 |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Provides hospital services | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Medivir AB
Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Provides hospital services | Health Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån